bioRxiv·19 AugOral administration of 1,10-phenanthroline-5-amine (PAA) significantly reduced amyloid plaque burden compared with untreated APP/PS1 micePreprint: experiments in animalsInterventionsPaper
AAIC 2025 Abstract·26 DecNovel properties of phenanthroline‐amine include binding to amyloid plaques and suppressing plaque growth in APP/PS1 mouse model of Alzheimer’s disease (AD)Experiments in animalsMechanismsPaper
AAIC 2025 Abstract·23 DecEvidence of miR‐153‐3p association with Alzheimer's disease (AD) and the mechanism of miR‐153‐3p on critical proteins suggest a therapeutic and biomarker potential of miR‐153‐3p in AD and related dementiasStudy in peopleMechanismsPaper
AAIC 2025 Abstract·23 DecEvidence of miR‐153‐3p association with Alzheimer's disease (AD) and the mechanism of miR‐153‐3p on critical proteins suggest a therapeutic and biomarker potential of miR‐153‐3p in AD and related dementiasStudy in peopleMechanismsPaper